DelveInsight's ' Frontotemporal Dementia - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Frontotemporal Dementia epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Study Period: 2017-2030
The DelveInsight Frontotemporal Dementia epidemiology report gives a thorough understanding of the Frontotemporal Dementia by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Frontotemporal Dementia in the US, Europe, and Japan. The report covers the detailed information of the Frontotemporal Dementia epidemiology scenario in seven major countries (US, EU5, and Japan).
The Frontotemporal Dementia epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Frontotemporal Dementia epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Frontotemporal Dementia epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.
The Frontotemporal Dementia epidemiology covered in the report provides historical as well as forecasted Frontotemporal Dementia epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.
The DelveInsight Frontotemporal Dementia report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.
We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.
1. Key Insights
2. Executive Summary of Frontotemporal Dementia
3. Frontotemporal Dementia: Disease Background and Overview
3.1. Introduction
3.2. Sign and Symptoms
3.3. Pathophysiology
3.4. Risk Factors
3.5. Diagnosis
4. Patient Journey
5. Epidemiology and Patient Population
5.1. Epidemiology Key Findings
5.2. Assumptions and Rationale: 7MM
5.3. Epidemiology Scenario: 7MM
5.3.1. Frontotemporal Dementia Epidemiology Scenario in the 7MM (2017- 2030)
5.4. United States Epidemiology
5.4.1. Frontotemporal Dementia Epidemiology Scenario in the United States (2017- 2030)
5.5. EU-5 Country-wise Epidemiology
5.5.1. Germany Epidemiology
5.5.1.1. Frontotemporal Dementia Epidemiology Scenario in Germany (2017- 2030)
5.5.2. France Epidemiology
5.5.2.1. Frontotemporal Dementia Epidemiology Scenario in France (2017- 2030)
5.5.3. Italy Epidemiology
5.5.3.1. Frontotemporal Dementia Epidemiology Scenario in Italy (2017- 2030)
5.5.4. Spain Epidemiology
5.5.4.1. Frontotemporal Dementia Epidemiology Scenario in Spain (2017- 2030)
5.5.5. United Kingdom Epidemiology
5.5.5.1. Frontotemporal Dementia Epidemiology Scenario in the United Kingdom (2017-2030)
5.6. Japan Epidemiology
5.6.1. Frontotemporal Dementia Epidemiology Scenario in Japan (2017- 2030)
6. Treatment Algorithm, Current Treatment, and Medical Practices
6.1. Frontotemporal Dementia Treatment and Management
6.2. Frontotemporal Dementia Treatment Algorithm
7. KOL Views
8. Unmet Needs
9. Appendix
9.1. Bibliography
9.2. Report Methodology
10. DelveInsight Capabilities
11. Disclaimer
12. About DelveInsight
*The table of contents is not exhaustive; will be provided in the final report
Table 1 Frontotemporal Dementia Epidemiology in 7MM (2017-2030)
Table 2 Frontotemporal Dementia Diagnosed and Treatable Cases in 7MM (2017-2030)
Table 3 Frontotemporal Dementia Epidemiology in the United States (2017-2030)
Table 4 Frontotemporal Dementia Diagnosed and Treatable Cases in the United States (2017-2030)
Table 5 Frontotemporal Dementia Epidemiology in Germany (2017-2030)
Table 6 Frontotemporal Dementia Diagnosed and Treatable Cases in Germany (2017-2030)
Table 7 Frontotemporal Dementia Epidemiology in France (2017-2030)
Table 8 Frontotemporal Dementia Diagnosed and Treatable Cases in France (2017-2030)
Table 9 Frontotemporal Dementia Epidemiology in Italy (2017-2030)
Table 10 Frontotemporal Dementia Diagnosed and Treatable Cases in Italy (2017-2030)
Table 11 Frontotemporal Dementia Epidemiology in Spain (2017-2030)
Table 12 Frontotemporal Dementia Diagnosed and Treatable Cases in Spain (2017-2030)
Table 13 Frontotemporal Dementia Epidemiology in the United Kingdom (2017-2030)
Table 14 Frontotemporal Dementia Diagnosed and Treatable Cases in the United Kingdom (2017-2030)
Table 15 Frontotemporal Dementia Epidemiology in Japan (2017-2030)
Table 16 Frontotemporal Dementia Diagnosed and Treatable Cases in Japan (2017-2030)
Figure 1 Frontotemporal Dementia Epidemiology in 7MM (2017-2030)
Figure 2 Frontotemporal Dementia Diagnosed and Treatable Cases in 7MM (2017-2030)
Figure 3 Frontotemporal Dementia Epidemiology in the United States (2017-2030)
Figure 4 Frontotemporal Dementia Diagnosed and Treatable Cases in the United States (2017-2030)
Figure 5 Frontotemporal Dementia Epidemiology in Germany (2017-2030)
Figure 6 Frontotemporal Dementia Diagnosed and Treatable Cases in Germany (2017-2030)
Figure 7 Frontotemporal Dementia Epidemiology in France (2017-2030)
Figure 8 Frontotemporal Dementia Diagnosed and Treatable Cases in France (2017-2030)
Figure 9 Frontotemporal Dementia Epidemiology in Italy (2017-2030)
Figure 10 Frontotemporal Dementia Diagnosed and Treatable Cases in Italy (2017-2030)
Figure 11 Frontotemporal Dementia Epidemiology in Spain (2017-2030)
Figure 12 Frontotemporal Dementia Diagnosed and Treatable Cases in Spain (2017-2030)
Figure 13 Frontotemporal Dementia Epidemiology in the United Kingdom (2017-2030)
Figure 14 Frontotemporal Dementia Diagnosed and Treatable Cases in the United Kingdom (2017-2030)
Figure 15 Frontotemporal Dementia Epidemiology in Japan (2017-2030)
Figure 16 Frontotemporal Dementia Diagnosed and Treatable Cases in Japan (2017-2030)
*The table of contents is not exhaustive; will be provided in the final report
